Securities Code: 300497
Securities Abbreviation: Fuxiang Shares
Announcement Number: 2026-061
Jiangxi Fuxiang Pharmaceutical Co., Ltd.
2026 Interim Performance Forecast
The Company and the Board of Directors guarantee that the information disclosed in this report is true, accurate, and complete, and contains no false records, misleading statements, or material omissions.
I. Performance Forecast for the Current Period
-
Performance Forecast Period: January 1, 2026, to June 30, 2026.
-
Performance Forecast: Expected net profit to be positive, turning losses into gains.
| Item | Reporting Period | Prior Year Period |
|---|---|---|
| Net profit attributable to shareholders of the listed company | Profit: RMB 16,500 million - RMB 21,450 million | Loss: RMB 691.12 million |
| Year-on-year growth | 2487% - 3204% | |
| Net profit after deducting non-recurring | Profit: RMB 16,100 million - RMB 21,050 million | Loss: RMB 3,217.98 million |
| gains and losses |